{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Chronic+Lung+Disease+of+Newborn", "query": { "condition": "Chronic Lung Disease of Newborn" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 132, "total_pages": 14, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Chronic+Lung+Disease+of+Newborn&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-06-11T09:15:05.553Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06609135", "title": "Relationship Between EIT and Respiratory Status in Very Preterm Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Lung Disease of Prematurity", "Bronchopulmonary Dysplasia", "Premature Lungs" ], "interventions": [ { "name": "Sentec LuMon Device (EIT system)", "type": "DEVICE" }, { "name": "Sentec Digital Monitoring System (transcutaneous CO2 monitor)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Lawrence Rhein", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Days", "maximum_age": null, "sex": "ALL", "summary": "5 Days and older" }, "enrollment_count": 20, "start_date": "2023-11-04", "completion_date": "2024-08-31", "has_results": true, "last_update_posted_date": "2025-10-09", "last_synced_at": "2026-06-11T09:15:05.553Z", "location_count": 1, "location_summary": "Worcester, Massachusetts", "locations": [ { "city": "Worcester", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06609135" }, { "nct_id": "NCT02502201", "title": "Environment Effect on Six-Minute Walk Test Performance", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Obstructive Pulmonary Disease", "Alpha-1 Antitrypsin Deficiency" ], "interventions": [ { "name": "six-minute walk study indoors", "type": "OTHER" }, { "name": "six-minute walk study outdoors", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 27, "start_date": "2015-10", "completion_date": "2017-08-30", "has_results": false, "last_update_posted_date": "2019-08-22", "last_synced_at": "2026-06-11T09:15:05.553Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02502201" }, { "nct_id": "NCT07275905", "title": "Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung Infection", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cystic Fibrosis (CF)", "Achromobacter Infection" ], "interventions": [ { "name": "AchromoPhage", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Ghady Haidar", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 12, "start_date": "2026-05-01", "completion_date": "2028-02", "has_results": false, "last_update_posted_date": "2026-04-07", "last_synced_at": "2026-06-11T09:15:05.553Z", "location_count": 2, "location_summary": "San Diego, California • Pittsburgh, Pennsylvania", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT07275905" }, { "nct_id": "NCT06350474", "title": "Impact of Discontinuing Dornase Alfa in People With CF on Highly Effective CFTR Modulator Therapy-A SIMPLIFY Sub-Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "Discontinuation of dornase alfa (Dnase)", "type": "OTHER" }, { "name": "Continuation of dornase alfa (Dnase)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Nicole Hamblett", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 477, "start_date": "2020-08-25", "completion_date": "2022-07-11", "has_results": true, "last_update_posted_date": "2024-11-26", "last_synced_at": "2026-06-11T09:15:05.553Z", "location_count": 81, "location_summary": "Birmingham, Alabama • Anchorage, Alaska • Tucson, Arizona + 69 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06350474" }, { "nct_id": "NCT04806620", "title": "Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Post-Acute COVID-19 Syndrome", "ME/CFS", "Rheumatic Arthritis", "Juvenile Rheumatoid Arthritis (JRA)", "Psoriatic Arthritis (PsA)", "Ankylosing Spondylitis (AS)", "Autoimmune Encephalitis", "Celiac Disease", "Celiac Disease in Children", "Chronic Lyme Disease", "Post-treatment Lyme Disease Syndrome", "Crohn's Disease", "Dysautonomia", "Anorexia Nervosa", "Bulimia Nervosa", "ARFID", "Avoidant / Restrictive Food Intake Disorder", "Ehlers Danlos Syndrome", "Endometriosis", "Fibromyalgia (FM)", "Long COVID", "Lupus", "Migraines", "Mast Cell Activation Syndrome", "Multiple Sclerosis", "Myalgic Encephalomyelitis (ME)", "Myasthenia Gravis, Generalized", "Myasthenia Gravis in Children", "Narcolepsy", "Obsessive Compulsive Disorder (OCD)", "PANDAS", "Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)", "POTS - Postural Orthostatic Tachycardia Syndrome", "General Anxiety Disorder, Social Anxiety Disorder", "PTSD - Post Traumatic Stress Disorder", "Psoriasis", "Traumatic Brain Injury", "Tourette's Syndrome", "Inflammatory Bowel Disease (IBD)", "Autoimmune Diseases", "Neurological Diseases or Conditions", "Psychiatric Disorder", "Sjogren's Syndrome", "Ulcerative Colitis and Crohn's Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Brain Inflammation Collaborative", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 10000, "start_date": "2023-07-05", "completion_date": "2030-12-31", "has_results": false, "last_update_posted_date": "2026-01-22", "last_synced_at": "2026-06-11T09:15:05.553Z", "location_count": 1, "location_summary": "Delafield, Wisconsin", "locations": [ { "city": "Delafield", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT04806620" }, { "nct_id": "NCT06350461", "title": "Impact of Discontinuing Hypertonic Saline in People With CF on Highly Effective CFTR Modulators- A SIMPLIFY Sub-Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "Discontinuation of hypertonic saline (HS)", "type": "OTHER" }, { "name": "Continuation of hypertonic saline (HS)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Nicole Hamblett", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 370, "start_date": "2020-08-25", "completion_date": "2022-07-11", "has_results": true, "last_update_posted_date": "2024-10-01", "last_synced_at": "2026-06-11T09:15:05.553Z", "location_count": 81, "location_summary": "Birmingham, Alabama • Anchorage, Alaska • Tucson, Arizona + 69 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06350461" }, { "nct_id": "NCT01105923", "title": "Study of an Intervention to Improve Problem List Accuracy and Use", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Attention Deficit Disorder With Hyperactivity", "Asthma", "COPD", "Breast Cancer", "Coronary Artery Disease", "Congestive Heart Failure", "Diabetes", "Glaucoma", "Hemophilia", "Hypertension", "Hyperthyroidism", "Hypothyroidism", "Myasthenia Gravis", "Osteoporosis", "Osteopenia", "Renal Failure", "Renal Insufficiency", "Sickle Cell Disease", "Stroke" ], "interventions": [ { "name": "MAPLE", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 140, "start_date": "2010-05", "completion_date": "2017-11", "has_results": false, "last_update_posted_date": "2015-02-02", "last_synced_at": "2026-06-11T09:15:05.553Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01105923" }, { "nct_id": "NCT00295061", "title": "Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Alpha 1-Antitrypsin Deficiency" ], "interventions": [ { "name": "Alpha-1 MP", "type": "DRUG" }, { "name": "alpha-1 proteinase inhibitor (human)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Grifols Therapeutics LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2006-05", "completion_date": "2007-02", "has_results": true, "last_update_posted_date": "2014-09-09", "last_synced_at": "2026-06-11T09:15:05.553Z", "location_count": 8, "location_summary": "Denver, Colorado • Gainesville, Florida • Miami, Florida + 5 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "New York", "state": "New York" }, { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00295061" }, { "nct_id": "NCT03673566", "title": "Clinical Evaluation of the \"NICU Clinical Decision Support Dashboard\" - CHMCO", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Preterm Birth", "Low; Birthweight, Extremely (999 Grams or Less)", "Neonatal Infection", "Satisfaction", "Stress", "Chronic Lung Disease", "Growth Acceleration", "Adverse Event" ], "interventions": [ { "name": "NICU Dashboard", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Philips Healthcare", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 0, "start_date": "2019-03-20", "completion_date": "2020-04-01", "has_results": false, "last_update_posted_date": "2020-09-24", "last_synced_at": "2026-06-11T09:15:05.553Z", "location_count": 1, "location_summary": "Omaha, Nebraska", "locations": [ { "city": "Omaha", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT03673566" }, { "nct_id": "NCT04722887", "title": "A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Participants With Alpha1-Antitrypsin Deficiency", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Alpha1-Antitrypsin Deficiency" ], "interventions": [ { "name": "Alpha-1 15%", "type": "BIOLOGICAL" }, { "name": "Liquid Alpha1-Proteinase Inhibitor (Human)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Grifols Therapeutics LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 17, "start_date": "2021-08-13", "completion_date": "2025-08-01", "has_results": false, "last_update_posted_date": "2025-12-12", "last_synced_at": "2026-06-11T09:15:05.553Z", "location_count": 5, "location_summary": "Los Angeles, California • Gainesville, Florida • Miami, Florida + 2 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04722887" } ] }